Vietnam Insulin Pump Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

The Vietnam Insulin Pump Market was valued at USD 86.27 Million in 2023, and is expected to reach USD 113.32 Million by 2029, rising at a CAGR of 4.85%. An insulin pump is a healthcare device employed for dispensing insulin into the patient for management of diabetes mellitus, also referred to as uninterrupted subcutaneous insulin management. A traditional insulin pump mainly comprises of three components which include a processing module, a disposable reservoir for insulin, and a disposable infusion set for subcutaneous insertion. Conventional insulin pumps deliver insulin from a reservoir inside the pump through tubing to a site on the skin that is linked to a smaller pliable plastic tube (cannula).

In contrast, insulin patch pumps employ a pliable plastic tube under the skin, but the insulin delivery reservoir and the cannula are integrated into a single "pod" that adheres to the skin with an adhesive patch. According to the survey preformed in 2020 among 37 countries including Vietnam, it has been observed that pumps were the most common mode used by doctors to penetrate insulin into the patient’s body after syringes and insulin pens.

As per the Ministry of Health, the diabetic population in Vietnam has reached almost five million in 2021, which is approximately 7.1% of the total adult population. Moreover, every year approximately 29,000 patients die due to diabetes every year in Vietnam. Insulin Pump Market has showcased a notable growth over recent years which can be ascribed to certain factors. Increase in prevalence of diabetes, growth in technological advancements associated with function of insulin pumps and rise in product launches related to diabetic care with FDA approval are anticipated to register an impressive growth to Vietnam Insulin Pump Market in the forecast period.

Key Market Drivers

Increase in Prevalence of Diabetes

Diabetes is a persistent medical condition that arises when the pancreas fails to generate an adequate amount of insulin or when the body is incapable of utilizing the insulin it generates efficiently. Insulin is a hormone that regulates the level of glucose in the bloodstream. Diabetes can be broadly categorized into three types which include Type 1 diabetes, Type 2 diabetes, and gestational diabetes. Individuals suffering from diabetes are vulnerable to infections caused by elevated blood sugar levels, weakened immune system, circulatory complications, and other concurrent conditions like high blood pressure, abnormal lipid metabolism, and cardiovascular diseases.

Diabetes has the possibility to become an epidemic and consequently, impose significant public health and financial burden in Vietnam. Despite the fact that the occurrence of diabetes in remote areas is still comparatively small, it is increasing. In prominent urban centers, diabetes is as prevalent as in other Western societies. A national survey was conducted in Vietnam in 2022 based on risk factors associated with type 2 diabetes and prediabetes mellitus. In this cross-sectional study, a total of 5244 individuals aged between 30 to 69 years old were enrolled.

The National Hospital of Endocrinology, Vietnam took blood samples from all participants to measure their fasting blood glucose level and conducted a 2-hour post load oral glucose tolerance test. It was observed that male participants aged 50 to 59 years old with hypertension and WHR risk had a higher prevalence of prediabetes. Diabetes was found to have a significant association with participants having hypertension. The study found that 17.9% of the participants had prediabetes and 7.3% had diabetes. The mean age of the participants was 49.62 ± 0.15 years, and more than half of them were females (52.0%) who had completed secondary to high school education.

Among the male group, 23.7% were overweight-obese, and 6.6% were underweight, which was higher than the female group's corresponding figures (19.9% overweight-obese and 5.0% underweight). The WHR risk was lower among male participants (20.2%) than female participants (88.4%). The prevalence of hypertension was 38.5% among male participants and 26.8% among female participants. The proportion of male participants with prediabetes and diabetes were 7.2% and 6.4%, respectively, while the corresponding figures for female participants were 6.2% and 4.5%. The insulin pumps have the capability to dispense minute quantities of insulin on a regular basis (basal), or a bolus dose within proximity to mealtime to regulate the spike in blood glucose (blood sugar) levels post-meal. This mode of delivery mirrors the body's natural release of insulin. The insulin pump can be synchronized with a continuous glucose monitor (CGM) to gain insight into the impact on blood glucose levels and adjust the insulin dosage accordingly in certain scenarios.

Technological Advancements

Due to the progress in technologies such as constant glucose monitors, traditional insulin pumps are transforming into more intelligent apparatuses that have the ability to automate insulin administration. The desire to create closed-loop systems has resulted in numerous collaborations between insulin pump and CGM producers. Presently, Medtronic is at the forefront with their 780G system, which is an "advanced hybrid closed loop" system. This system enables Medtronic pumps to receive information from linked Medtronic CGMs and adjust their insulin distribution independently. Insulet revealed in 2022 that the FDA had authorized its Omnipod 5 Automated Insulin Delivery System for individuals aged six years and above who have type 1 diabetes.

Omnipod 5, which is the initial tubeless automated insulin delivery system, synergizes with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and smartphone management to automatically regulate insulin levels and prevent hyperglycemia and hypoglycemia. Moreover, Tandem Diabetes Care obtained approval from the FDA for bolus insulin dosage on the t:slim X2 insulin pump via the t:connect mobile application in mid-February 2022. This achievement marked the first FDA-approved smartphone app that can commence insulin administration on iOS and Android operating systems.

Rising Demand for Personalized Diabetes Management

The growing demand for personalized diabetes management is a key driver of the insulin pump market in Vietnam. As healthcare shifts toward more individualized care, diabetic patients are increasingly seeking tailored treatment options to better manage their condition. Insulin pumps offer a sophisticated solution, providing continuous insulin delivery that can be adjusted based on individual needs, lifestyle, and glucose levels. This customization allows for improved blood sugar control and a reduction in complications, especially for individuals with type 1 diabetes.

Personalized diabetes management is also supported by technological advancements such as continuous glucose monitoring (CGM) systems, which provide real-time data on blood glucose levels. Insulin pumps integrated with CGM allow for automated insulin adjustments, making it easier for patients to manage their diabetes without constant monitoring. As awareness of the benefits of personalized care grows, there is a rising preference for insulin pumps over traditional insulin delivery methods. This trend is also fueled by the increasing access to advanced medical devices among Vietnam’s growing middle class, which is willing to invest in personalized healthcare solutions.

Key Market Challenges

Limited Awareness and Accessibility

Limited awareness and accessibility pose significant barriers to the growth of the insulin pump market in Vietnam. Firstly, a lack of awareness about insulin pumps among healthcare professionals and patients hampers the adoption of this advanced diabetes management technology. Without adequate knowledge about the benefits and functionalities of insulin pumps, healthcare providers may not recommend them as a treatment option, while patients may not actively seek them out. Additionally, limited accessibility to insulin pumps further exacerbates this issue, particularly in rural or remote areas where healthcare infrastructure may be underdeveloped. The absence of specialized diabetes care centers and trained healthcare professionals capable of supporting insulin pump therapy restricts patient access to these devices. Moreover, the high cost of insulin pumps presents an affordability barrier for many individuals, further limiting accessibility.

High Cost

The high cost of insulin pumps presents a significant impediment to the growth of the market in Vietnam. Affordability is a critical factor influencing the adoption of insulin pump therapy, particularly in a country where healthcare expenses can place a considerable financial burden on individuals and families. The upfront cost of purchasing an insulin pump, along with ongoing expenses for supplies, maintenance, and training, may be prohibitive for many patients, especially those from lower-income backgrounds. Moreover, limited insurance coverage and reimbursement options for insulin pumps further exacerbate the financial barrier, forcing patients to bear the full cost out-of-pocket. As a result, individuals with diabetes may opt for less expensive treatment alternatives, such as insulin injections or oral medications, despite the potential benefits of insulin pump therapy in terms of improved glycemic control and quality of life.

Key Market Trends

Telemedicine and Remote Monitoring

Telemedicine and remote monitoring hold significant potential to positively influence the growth of the insulin pump market in Vietnam. As the country faces challenges related to healthcare access and infrastructure, telemedicine platforms can bridge the gap by enabling remote consultations between patients and healthcare providers. This allows individuals with diabetes, including those in rural or underserved areas, to access specialized care and guidance regarding insulin pump therapy without the need for in-person visits to healthcare facilities.

Moreover, remote monitoring technologies integrated with insulin pumps enable continuous tracking of glucose levels and treatment adherence, empowering healthcare providers to remotely monitor patients' progress and intervene proactively in case of any issues. This not only improves patient safety and outcomes but also enhances the efficiency of diabetes management by reducing the need for frequent clinic visits and hospitalizations. By leveraging telemedicine and remote monitoring solutions, healthcare providers can extend the reach of diabetes care, increase patient engagement, and ultimately drive the adoption of insulin pump therapy as a preferred treatment option for individuals with diabetes in Vietnam. However, ensuring reliable internet connectivity and promoting digital literacy among both patients and healthcare professionals will be essential to realize the full potential of these technologies in advancing diabetes care across the country.

Focus on Continuous Glucose Monitoring (CGM) Integration

The focus on continuous glucose monitoring (CGM) integration is poised to significantly influence the growth of the insulin pump market in Vietnam. CGM technology provides real-time insights into glucose levels, allowing for more precise and timely adjustments to insulin therapy, which can lead to better glycemic control and reduced risk of complications. By integrating CGM functionality into insulin pump systems, manufacturers offer users a seamless and comprehensive solution for diabetes management.

This integration eliminates the need for separate CGM devices and simplifies the monitoring process, making it more convenient and user-friendly for individuals with diabetes. Furthermore, the combination of CGM and insulin pump therapy enables automated insulin delivery algorithms, known as hybrid, closed-loop systems, which adjust insulin doses based on real-time glucose readings, further optimizing blood sugar levels while minimizing the risk of hypoglycemia. As awareness grows about the benefits of CGM-integrated insulin pumps among healthcare professionals and patients in Vietnam, demand for these advanced technologies is expected to rise, driving market growth, and improving outcomes for individuals living with diabetes in the country.

Segmental Insights

Type Insights

Based on Type, Patch Pumps emerged as the fastest growing segment in the Vietnam Insulin Pump market during the forecast period. Patch pumps are more compact, lightweight, and discreet than traditional insulin pumps, offering enhanced comfort for patients seeking a less visible solution for diabetes management. Unlike conventional pumps, which rely on tubing and external devices, patch pumps are adhesive and attach directly to the skin, making them more convenient for extended wear, especially for those with active lifestyles.

As technology advances, patch pumps now feature wireless connectivity, remote control capabilities, and integration with continuous glucose monitoring (CGM) systems, offering a more streamlined and flexible approach to diabetes management. Their smaller, tubeless design enhances comfort, making them ideal for individuals who find traditional pumps bulky. With the growing trend towards personalized healthcare, patch pumps allow users to adjust insulin delivery to meet their specific needs, driving their increasing popularity in the market.

Application Insights

Based on Application, the Type 1 diabetes emerged as the dominating segment in the Vietnam insulin pump market in 2023. Type 1 diabetes occurs when the body cannot produce insulin, requiring individuals to rely on external insulin sources, typically via injections or insulin pumps. Insulin pumps are particularly beneficial for these patients, offering a continuous insulin supply that helps maintain stable blood glucose levels and minimizes the risk of complications. Type 1 diabetes typically develops in childhood or adolescence, meaning these patients need lifelong insulin management. This ongoing need for consistent insulin therapy makes insulin pumps an ideal solution for effective diabetes management.

Technological advancements in insulin pumps such as smaller, more convenient, and comfortable designs have made them even more appealing. These devices provide precise insulin delivery, improving diabetes control and appealing to Type 1 diabetes patients who require constant monitoring. Compared to traditional injections, insulin pumps offer more efficient and consistent insulin delivery, mimicking the body’s natural insulin release, leading to better glucose control and fewer complications. While Type 2 diabetes is becoming more prevalent, Type 1 diabetes still accounts for a larger share of the population requiring insulin pumps, as these patients typically need insulin therapy earlier in their treatment. Thus, the Type 1 diabetes segment continues to dominate the insulin pump market due to the sustained and direct need for insulin management.

Regional Insights

Based on Region, Southern Vietnam emerged as the dominating region in the Vietnam Insulin Pump Market in 2023. The southern region, particularly cities like Ho Chi Minh City, has a higher concentration of healthcare facilities, specialized diabetes clinics, and trained healthcare professionals compared to other regions. This concentration of healthcare resources facilitates better access to insulin pump therapy and related support services, making it more convenient for individuals with diabetes to seek treatment in the southern region. Additionally, the southern region tends to have higher levels of economic development and disposable income, which may enable more individuals to afford the upfront cost of insulin pumps and ongoing expenses for supplies and maintenance. Furthermore, the southern region often serves as a hub for medical tourism and healthcare innovation, attracting investments from manufacturers and distributors of medical devices, including insulin pumps.

Key Market Players

• Roche Vietnam Co., Ltd.
• Medtronic Vietnam
• Abbott Laboratories GmbH
• B. Braun Vietnam Co., Ltd.
• NIPRO PHARMA VIETNAM CO., LTD.
• Novo Nordisk Pharma Operations A/S Vietnam

Report Scope:

In this report, the Vietnam Insulin Pump Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vietnam Insulin Pump Market, By Type:

• Traditional Insulin Pumps
• Patch Pumps

Vietnam Insulin Pump Market, By Insulin Used:

• Short Acting Insulin
• Rapid Acting Insulin

Vietnam Insulin Pump Market, By Application:

• Type 1 Diabetes
• Type 2 Diabetes

Vietnam Insulin Pump Market, By End User:

• Hospitals & Clinics
• Diagnostic Centers
• Home Care

Vietnam Insulin Pump Market, By Region:

• Southern Vietnam
• Northern Vietnam
• Central Vietnam

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Vietnam Insulin Pump Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.